Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories nutritional Products — Segment Depreciation & Amortization ($M) ($M)
Postgres DB segment_values + Form 10-K/10-Q XBRL
Latest, FY2025
175
Period ended Dec 31, 2025
Change on a year earlier
+10.1%
159 in FY2024
History
17 years
Since FY2009
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Abbott Laboratories Nutritional Products — Segment Depreciation & Amortization ($M) ($M), annual FY2009–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-depr-nut
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.